AET - CVS Is A Prescription For Profits
CVS Health Corporation (NYSE: CVS) seems to be one of the most mis-understood stocks in the market today. The company is trying to gain regulatory approval to acquire Aetna (NYSE: AET) in a multi-billion-dollar merger. Of course, any company making such a large acquisition faces risks. However, if we look at what investors get with CVS if the merger clears (or even if it doesn’t), the stock looks dirt cheap at these levels.
Worst case scenario?
If the worst-case scenario for CVS is the company’s huge merger doesn’t go through, investors should